Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
about
Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase IVariation in L-arginine intake follow demographics and lifestyle factors that may impact cardiovascular disease risk.Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular riskImpaired Endothelial Nitric Oxide Synthase Homodimer Formation Triggers Development of Transplant Vasculopathy - Insights from a Murine Aortic Transplantation Model.The endothelial cell in health and disease: its function, dysfunction, measurement and therapy.Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis.LXRα regulates macrophage arginase 1 through PU.1 and interferon regulatory factor 8.Unveiling differences between patients with acute coronary syndrome with and without ST elevation through fingerprinting with CE-MS and HILIC-MS targeted analysis.The prevention of endothelial dysfunction through endothelial cell apoptosis inhibition in a hypercholesterolemic rabbit model: the effect of L-arginine supplementationOral administration of L-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase.Early prevention by L-Arginine attenuates coronary atherosclerosis in a model of hypercholesterolemic animals; no positive results for treatment.LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia.
P2860
Q34679092-42B75B97-4D6A-45FD-B3EB-9B649CCBDB32Q36464510-783870A2-A873-4E4A-83E8-2AFFF22E5513Q37102697-8FB60F4B-5D6A-4B14-ADCD-2AE49C4AFACCQ37370572-D1BEC709-9730-4322-8C4A-2BD59F311510Q37435334-FFC6EE83-47E0-4EB9-A059-A21190F6C8ABQ37662195-72E7AC60-3A02-4D84-8694-37F401301B12Q37951442-C48926AF-F2A7-49B5-B2CA-ED750AE85985Q38570304-586FAA60-8B65-4246-8598-6283AFDE2769Q40733394-1D6A48FF-6F63-45F6-ACA3-6C760FF38344Q41808077-AB04F652-3578-427B-9267-ADEA30F06424Q42585427-8FD1F45D-9376-4D2D-B601-BB82BBA4C285Q43148243-3E95EBCB-7526-4BBE-9551-416B68650C9BQ55353903-B47FDD72-FACB-492A-9E48-05A7D3B0671C
P2860
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
@ast
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
@en
type
label
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
@ast
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
@en
prefLabel
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
@ast
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
@en
P2093
P2860
P356
P1476
Mechanisms of disease: L-arginine in coronary atherosclerosis--a clinical perspective.
@en
P2093
Charalambos Antoniades
Dimitris Tousoulis
Elli Stefanadi
Gerasimos Siasos
Rainer H Böger
P2860
P304
P356
10.1038/NCPCARDIO0878
P577
2007-05-01T00:00:00Z